ANI Pharmaceuticals announced positive results from its Phase 4 open-label, single-arm SYNCHRONICITY clinical trial. No additional details were provided in the initial release.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
